The global moderate-to-severe acne treatment market was valued at US$ 1.2 Billion in 2022 and is expected to reach US$ 2.4 Billion by 2033. The retinoid therapy with around 25.6% value share, has topped the global market within the treatment category in 2022 and is expected to grow at a CAGR of close to 6.5% over the forecast period (2023 to 2033)
Market Outlook:
| Data Points | Market Insights |
|---|---|
| Market Value 2022 | US$ 1.2 Billion |
| Market Value 2023 | US$ 1.3 Billion |
| Market Value 2033 | US$ 2.4 Billion |
| CAGR 2023 to 2033 | 6.5% |
| Market Share of Top 5 Countries | 57.4% |
| Key Market Players | Johnson & Johnson, Bayer AG, Galderma, Allergan, Roche, Valeant Pharmaceuticals, Stiefel Laboratories, Pfizer, Foamix Pharmaceuticals, La Roche-Posay, Proactiv, Cipla Limited, GlaxoSmithKline, Janssen Pharmaceuticals Inc. & Sanofi. |
Acne is a prevalent skin condition, affecting millions of people worldwide. The incidence of moderate-to-severe acne has been increasing, driven by factors such as hormonal changes, lifestyle habits, and genetic predisposition. This growing prevalence fuels the demand for effective treatments.
There is a growing awareness among individuals about the impact of acne on their appearance and quality of life. More people with moderate-to-severe acne are seeking professional treatment and are willing to invest in products and therapies to address their condition, driving market growth.
Economic growth and rising disposable incomes in many regions have led to increased healthcare spending. Individuals are willing to invest in premium skincare products, dermatology consultations, and advanced acne treatments. This trend boosts the demand for moderate-to-severe acne treatment products and therapies.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global market for moderate-to-severe acne treatment was around 12.5% of the overall US$ 9.6 Billion of the global acne treatment market in 2022.
There is a growing demand for effective treatments for moderate-to-severe acne. Individuals with more severe forms of acne often seek professional help and are willing to invest in products and therapies that can provide significant improvement. The increasing awareness and social impact of acne drive the demand for treatments, contributing to sales growth.
Advancements in acne treatment have led to more effective therapies for moderate-to-severe acne. New ingredients, formulations, and delivery systems enhance treatment outcomes and reduce the severity and duration of acne lesions. The improved efficacy of treatments increases patient satisfaction and contributes to sales growth.
Increased awareness about the impact of acne on physical appearance and quality of life has led individuals to seek professional treatment. Educational campaigns and information dissemination through various media platforms have improved awareness about the availability of effective treatments for moderate-to-severe acne. This increased awareness has driven sales growth in the market.
Owed to the above factors, the global market is projected to grow at CAGR of 6.5% in forecasted period.
There is huge opportunity for market players to develop and introduce advanced treatment modalities for moderate-to-severe acne. This includes exploring innovative technologies such as laser therapies, light-based treatments, chemical peels, and photodynamic therapy. Advancements in these modalities provide more effective and efficient acne treatment options, attracting both patients and healthcare professionals.
Combination therapies involving the use of multiple treatment modalities or a combination of medications offer an opportunity for improved outcomes in moderate-to-severe acne treatment. By combining different therapeutic approaches, such as topical medications, oral medications, and physical treatments, synergistic effects can be achieved, leading to better efficacy and patient satisfaction.
The demand for skincare products specifically formulated for moderate-to-severe acne presents an opportunity for new product development. This includes the development of non-comedogenic, oil-free, and acne-fighting skincare products that address the unique needs of individuals with moderate-to-severe acne. Targeted skincare products can complement medical treatments and improve overall outcomes.
The integration of telemedicine and digital health solutions in acne treatment offers opportunities for remote consultations, follow-up care, and patient monitoring. Telemedicine platforms can enable access to specialized dermatological care, particularly in underserved areas. Digital health tools, such as mobile applications for acne tracking and management, can enhance patient engagement and treatment adherence.
Principal Consultant
The cost of moderate-to-severe acne treatments, including prescription medications and procedures, can be a significant barrier for some individuals. Expensive treatments may not be accessible or affordable for all patients, limiting their options for effective acne management. The cost-effectiveness of treatments and insurance coverage play crucial roles in addressing this restraint.
Access to specialized dermatological care can be limited in some regions or underserved areas. The availability of dermatologists and specialized clinics may be scarce, making it challenging for individuals with moderate-to-severe acne to receive timely and appropriate treatment. Improving access to dermatological care is essential to address this restraint.
Antibiotics are commonly used in the treatment of moderate-to-severe acne, but antibiotic resistance is a growing concern. Prolonged or inappropriate use of antibiotics can contribute to the development of resistant bacteria, reducing treatment efficacy and limiting future treatment options. Finding alternative approaches to acne treatment and reducing reliance on antibiotics are important considerations.
The USA occupies 37.4% of market share in 2022 globally. The pharmaceutical industry plays a crucial role in the moderate-to-severe acne treatment market in the United States. Several companies develop and market prescription medications specifically indicated for moderate-to-severe acne. These medications include topical formulations, oral medications, and combination therapies. The pharmaceutical market's dynamics, including competition and pricing, influence the availability and accessibility of acne treatments. This makes USA prominent market for moderate-to-severe acne treatment in North America.
Japan expenditure on moderate-to-severe acne treatment in 2022 was US$ 61.9 Million. Japan is at the forefront of technological advancements in the healthcare industry. Japan is known for its advancements in skincare technology and product development. The market offers a wide range of innovative acne treatment products, including topical formulations, skincare devices, and specialized cosmetics. Advanced technology and unique formulations contribute to the growth and competitiveness of the market.
Traditional and natural skincare approaches have a significant presence in the Japanese market. Some individuals with moderate-to-severe acne may seek alternative treatments, including herbal remedies, traditional medicine, and natural skincare products.
In 2022, the China held a significant share in the East Asia market and is expected to present lucrative growth of 6.1% CAGR over the forecast period. China has a thriving e-commerce market, and online platforms play a significant role in the distribution and sales of skincare products, including acne treatments. Online shopping platforms provide convenience and accessibility, allowing individuals to access a wide range of products for moderate-to-severe acne treatment.
Chinese consumers are becoming more educated about skincare and are increasingly focused on maintaining healthy and clear skin. They are receptive to innovative skincare products and treatment options, including those targeted at moderate-to-severe acne.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
By treatment, retinoid therapy held 25.6% market share in world in 2022.
The moderate-to-severe acne treatment market, specifically focusing on retinoid therapy, is a significant segment within the dermatology market. Retinoids are a class of medications derived from vitamin A that are commonly used in the treatment of acne. They work by reducing inflammation, promoting skin cell turnover, and preventing the formation of comedones.
Retinoids, including topical retinoids like tretinoin, adapalene, and tazarotene, have been proven to be highly effective in treating moderate-to-severe acne. Their ability to target multiple aspects of acne pathogenesis contributes to their popularity and market demand.
The market value of topical mode is US$ 574.3 Million, representing a sizable 46.1% market share in 2022. The moderate-to-severe acne treatment market, with a focus on topical treatments, plays a crucial role in addressing the needs of individuals with more severe forms of acne. Topical treatments are applied directly to the skin and can include various formulations and active ingredients targeting acne symptoms and underlying causes.
Combination topical therapies are commonly prescribed for moderate-to-severe acne. These combinations may include a combination of active ingredients such as retinoids, benzoyl peroxide, antibiotics, or azelaic acid. Combining different agents with complementary mechanisms of action can provide enhanced efficacy in managing acne symptoms.
The hospitals have a considerable presence in the moderate-to-severe acne treatment market, accounting for 34.9% value share in 2022, and exhibiting a high CAGR of 5.2% over the forecast period. In some cases, individuals with severe acne may require hospitalization for intensive treatment. This is typically reserved for cases where acne is causing significant physical or psychological distress and requires specialized care. Inpatient dermatology services in hospitals can provide a multidisciplinary approach to managing severe acne.
Some hospitals have specialized dermatology departments equipped with phototherapy units and laser devices. These treatments can be used in the management of moderate-to-severe acne, particularly for patients who have not responded well to conventional therapies.
Various firms active within the acne treatment industry are actively seeking collaborations with healthcare providers, and research institutions to can encourage innovation. Introduction of new and effective treatment modalities has been emphasized a lot.
Similarly, recent developments related to the companies active within the moderate-to-severe acne treatment have been tracked by the team at Future Market Insights, which are available in the full report.
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2017 to 2022 |
| Market Analysis | US$ Million for Value |
| Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East and Africa (MEA) |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, Germany, Italy, France, UK, Spain, BENELUX, Russia, China, Japan, South Korea, India, Indonesia, Thailand, Malaysia, Australia, New Zealand, GCC countries, Türkiye, Northern Africa and South Africa. |
| Key Market Segments Covered | Treatment, Route of Administration, Distribution Channel and Region |
| Key Companies Profiled |
|
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Pricing | Available upon Request |
The market size of moderate-to-severe acne treatment is US$ 1.3 billion in 2023.
The market is expected to expand at a CAGR of 6.2%.
Increasing investment in therapies and products and social impact of acne.
The most effective acne treatment is retinoid therapy.
The United States holds massive portion of the market.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Value Added Insights 4.1. Treatment Adoption / Usage Analysis 4.2. Reimbursement Scenario 4.3. Regulatory Landscape 4.4. PESTEL Analysis 4.5. Porter’s Analysis 4.6. Patient Treatment Regime 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Healthcare Expenditure Outlook 5.1.3. Global Life Expectancy Outlook 5.2. Forecast Factors - Relevance & Impact 5.2.1. Key Player’s Historic Growth 5.2.2. Increasing Cases of Skin Disorders 5.2.3. Favourable Government Regulations 5.2.4. Rising Demand for Topical Treatments 5.2.5. Technological Advancement in the Moderate-to-Severe Acne Treatment 5.2.6. Increasing Prevalence of Acne Vulgaris 5.2.7. Growing Demand for Laser based Treatments 5.3. Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. Global Market Demand (in Value or Size in US$ Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033 6.1. Historical Market Value (US$ Million) Analysis, 2017 to 2022 6.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033 6.2.1. Y-o-Y Growth Trend Analysis 6.2.2. Absolute $ Opportunity Analysis 7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Treatment 7.1. Introduction / Key Findings 7.2. Historical Market Size (US$ Million) Analysis By Treatment, 2017 to 2022 7.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Treatment, 2023 to 2033 7.3.1. Antibiotics 7.3.2. Retinoid Therapy 7.3.3. Hormonal Drugs 7.3.4. Anti-Inflammatory Drugs 7.3.5. Chemical Peels 7.3.6. Laser Devices 7.3.7. Radiofrequency Devices 7.4. Market Attractiveness Analysis By Treatment 8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Route of Administration 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Million) Analysis By Route of Administration, 2017 to 2022 8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Route of Administration, 2023 to 2033 8.3.1. Oral 8.3.2. Topical 8.3.3. Injectables 8.4. Market Attractiveness Analysis By Route of Administration 9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Distribution Channel 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Million) Analysis By Distribution Channel, 2017 to 2022 9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Distribution Channel, 2023 to 2033 9.3.1. Hospitals 9.3.2. Clinics 9.3.3. Pharmacies & Drug Stores 9.3.4. e-Commerce 9.3.5. Others 9.4. Market Attractiveness Analysis By Distribution Channel 10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Region 10.1. Introduction 10.2. Historical Market Size (US$ Million) Analysis By Region, 2017 to 2022 10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Region, 2023 to 2033 10.3.1. North America 10.3.2. Latin America 10.3.3. Europe 10.3.4. South Asia 10.3.5. East Asia 10.3.6. Oceania 10.3.7. Middle East & Africa (MEA) 10.4. Market Attractiveness Analysis By Region 11. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 11.1. Introduction 11.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2017 to 2022 11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033 11.3.1. By Country 11.3.1.1. USA 11.3.1.2. Canada 11.3.2. By Treatment 11.3.3. By Route of Administration 11.3.4. By Distribution Channel 11.4. Market Attractiveness Analysis 11.4.1. By Country 11.4.2. By Treatment 11.4.3. By Route of Administration 11.4.4. By Distribution Channel 11.5. Country Level Analysis & Forecast 11.5.1. USA Market Analysis 11.5.1.1. Introduction 11.5.1.2. Market Analysis and Forecast by Market Taxonomy 11.5.1.2.1. By Treatment 11.5.1.2.2. By Route of Administration 11.5.1.2.3. By Distribution Channel 11.5.2. Canada Market Analysis 11.5.2.1. Introduction 11.5.2.2. Market Analysis and Forecast by Market Taxonomy 11.5.2.2.1. By Treatment 11.5.2.2.2. By Route of Administration 11.5.2.2.3. By Distribution Channel 11.6. Market Trends 11.7. Key Market Participants - Intensity Mapping 11.8. Drivers and Restraints - Impact Analysis 12. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 12.1. Introduction 12.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2017 to 2022 12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033 12.3.1. By Country 12.3.1.1. Brazil 12.3.1.2. Mexico 12.3.1.3. Argentina 12.3.1.4. Rest of Latin America 12.3.2. By Treatment 12.3.3. By Route of Administration 12.3.4. By Distribution Channel 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. By Treatment 12.4.3. By Route of Administration 12.4.4. By Distribution Channel 12.5. Country Level Analysis & Forecast 12.5.1. Brazil Market Analysis 12.5.1.1. Introduction 12.5.1.2. Market Analysis and Forecast by Market Taxonomy 12.5.1.2.1. By Treatment 12.5.1.2.2. By Route of Administration 12.5.1.2.3. By Distribution Channel 12.5.2. Mexico Market Analysis 12.5.2.1. Introduction 12.5.2.2. Market Analysis and Forecast by Market Taxonomy 12.5.2.2.1. By Treatment 12.5.2.2.2. By Route of Administration 12.5.2.2.3. By Distribution Channel 12.5.3. Argentina Market Analysis 12.5.3.1. Introduction 12.5.3.2. Market Analysis and Forecast by Market Taxonomy 12.5.3.2.1. By Treatment 12.5.3.2.2. By Route of Administration 12.5.3.2.3. By Distribution Channel 12.6. Market Trends 12.7. Key Market Participants - Intensity Mapping 12.8. Drivers and Restraints - Impact Analysis 13. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033 13.1. Introduction 13.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2017 to 2022 13.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033 13.3.1. By Country 13.3.1.1. Germany 13.3.1.2. France 13.3.1.3. Italy 13.3.1.4. UK 13.3.1.5. Spain 13.3.1.6. Russia 13.3.1.7. BENELUX 13.3.1.8. Rest of Europe 13.3.2. By Treatment 13.3.3. By Route of Administration 13.3.4. By Distribution Channel 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Treatment 13.4.3. By Route of Administration 13.4.4. By Distribution Channel 13.5. Country Level Analysis & Forecast 13.5.1. Germany Market Analysis 13.5.1.1. Introduction 13.5.1.2. Market Analysis and Forecast by Market Taxonomy 13.5.1.2.1. By Treatment 13.5.1.2.2. By Route of Administration 13.5.1.2.3. By Distribution Channel 13.5.2. France Market Analysis 13.5.2.1. Introduction 13.5.2.2. Market Analysis and Forecast by Market Taxonomy 13.5.2.2.1. By Treatment 13.5.2.2.2. By Route of Administration 13.5.2.2.3. By Distribution Channel 13.5.3. Italy Market Analysis 13.5.3.1. Introduction 13.5.3.2. Market Analysis and Forecast by Market Taxonomy 13.5.3.2.1. By Treatment 13.5.3.2.2. By Route of Administration 13.5.3.2.3. By Distribution Channel 13.5.4. UK Market Analysis 13.5.4.1. Introduction 13.5.4.2. Market Analysis and Forecast by Market Taxonomy 13.5.4.2.1. By Treatment 13.5.4.2.2. By Route of Administration 13.5.4.2.3. By Distribution Channel 13.5.5. Spain Market Analysis 13.5.5.1. Introduction 13.5.5.2. Market Analysis and Forecast by Market Taxonomy 13.5.5.2.1. By Treatment 13.5.5.2.2. By Route of Administration 13.5.5.2.3. By Distribution Channel 13.5.6. Russia Market Analysis 13.5.6.1. Introduction 13.5.6.2. Market Analysis and Forecast by Market Taxonomy 13.5.6.2.1. By Treatment 13.5.6.2.2. By Route of Administration 13.5.6.2.3. By Distribution Channel 13.5.7. BENELUX Market Analysis 13.5.7.1. Introduction 13.5.7.2. Market Analysis and Forecast by Market Taxonomy 13.5.7.2.1. By Treatment 13.5.7.2.2. By Route of Administration 13.5.7.2.3. By Distribution Channel 13.6. Market Trends 13.7. Key Market Participants - Intensity Mapping 13.8. Drivers and Restraints - Impact Analysis 14. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 14.1. Introduction 14.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2017 to 2022 14.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033 14.3.1. By Country 14.3.1.1. India 14.3.1.2. Thailand 14.3.1.3. Indonesia 14.3.1.4. Malaysia 14.3.1.5. Rest of South Asia 14.3.2. By Treatment 14.3.3. By Route of Administration 14.3.4. By Distribution Channel 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Treatment 14.4.3. By Route of Administration 14.4.4. By Distribution Channel 14.5. Country Level Analysis & Forecast 14.5.1. India Market Analysis 14.5.1.1. Introduction 14.5.1.2. Market Analysis and Forecast by Market Taxonomy 14.5.1.2.1. By Treatment 14.5.1.2.2. By Route of Administration 14.5.1.2.3. By Distribution Channel 14.5.2. Thailand Market Analysis 14.5.2.1. Introduction 14.5.2.2. Market Analysis and Forecast by Market Taxonomy 14.5.2.2.1. By Treatment 14.5.2.2.2. By Route of Administration 14.5.2.2.3. By Distribution Channel 14.5.3. Indonesia Market Analysis 14.5.3.1. Introduction 14.5.3.2. Market Analysis and Forecast by Market Taxonomy 14.5.3.2.1. By Treatment 14.5.3.2.2. By Route of Administration 14.5.3.2.3. By Distribution Channel 14.5.4. Malaysia Market Analysis 14.5.4.1. Introduction 14.5.4.2. Market Analysis and Forecast by Market Taxonomy 14.5.4.2.1. By Treatment 14.5.4.2.2. By Route of Administration 14.5.4.2.3. By Distribution Channel 14.6. Market Trends 14.7. Key Market Participants - Intensity Mapping 14.8. Drivers and Restraints - Impact Analysis 15. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 15.1. Introduction 15.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2017 to 2022 15.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033 15.3.1. By Country 15.3.1.1. China 15.3.1.2. Japan 15.3.1.3. South Korea 15.3.2. By Treatment 15.3.3. By Route of Administration 15.3.4. By Distribution Channel 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Treatment 15.4.3. By Route of Administration 15.4.4. By Distribution Channel 15.5. Country Level Analysis & Forecast 15.5.1. China Market Analysis 15.5.1.1. Introduction 15.5.1.2. Market Analysis and Forecast by Market Taxonomy 15.5.1.2.1. By Treatment 15.5.1.2.2. By Route of Administration 15.5.1.2.3. By Distribution Channel 15.5.2. Japan Market Analysis 15.5.2.1. Introduction 15.5.2.2. Market Analysis and Forecast by Market Taxonomy 15.5.2.2.1. By Treatment 15.5.2.2.2. By Route of Administration 15.5.2.2.3. By Distribution Channel 15.5.3. South Korea Market Analysis 15.5.3.1. Introduction 15.5.3.2. Market Analysis and Forecast by Market Taxonomy 15.5.3.2.1. By Treatment 15.5.3.2.2. By Route of Administration 15.5.3.2.3. By Distribution Channel 15.6. Market Trends 15.7. Key Market Participants - Intensity Mapping 15.8. Drivers and Restraints - Impact Analysis 16. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033 16.1. Introduction 16.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2017 to 2022 16.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033 16.3.1. By Country 16.3.1.1. Australia 16.3.1.2. New Zealand 16.3.2. By Treatment 16.3.3. By Route of Administration 16.3.4. By Distribution Channel 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Treatment 16.4.3. By Route of Administration 16.4.4. By Distribution Channel 16.5. Country Level Analysis & Forecast 16.5.1. Australia Market Analysis 16.5.1.1. Introduction 16.5.1.2. Market Analysis and Forecast by Market Taxonomy 16.5.1.2.1. By Treatment 16.5.1.2.2. By Route of Administration 16.5.1.2.3. By Distribution Channel 16.5.2. New Zealand Market Analysis 16.5.2.1. Introduction 16.5.2.2. Market Analysis and Forecast by Market Taxonomy 16.5.2.2.1. By Treatment 16.5.2.2.2. By Route of Administration 16.5.2.2.3. By Distribution Channel 16.6. Market Trends 16.7. Key Market Participants - Intensity Mapping 16.8. Drivers and Restraints - Impact Analysis 17. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033 17.1. Introduction 17.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2017 to 2022 17.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033 17.3.1. By Country 17.3.1.1. GCC Countries 17.3.1.2. Türkiye 17.3.1.3. Northern Africa 17.3.1.4. South Africa 17.3.1.5. Rest of Middle East and Africa 17.3.2. By Treatment 17.3.3. By Route of Administration 17.3.4. By Distribution Channel 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Treatment 17.4.3. By Route of Administration 17.4.4. By Distribution Channel 17.5. Country Level Analysis & Forecast 17.5.1. GCC Countries Market Analysis 17.5.1.1. Introduction 17.5.1.2. Market Analysis and Forecast by Market Taxonomy 17.5.1.2.1. By Treatment 17.5.1.2.2. By Route of Administration 17.5.1.2.3. By Distribution Channel 17.5.2. Türkiye Market Analysis 17.5.2.1. Introduction 17.5.2.2. Market Analysis and Forecast by Market Taxonomy 17.5.2.2.1. By Treatment 17.5.2.2.2. By Route of Administration 17.5.2.2.3. By Distribution Channel 17.5.3. Northern Africa Market Analysis 17.5.3.1. Introduction 17.5.3.2. Market Analysis and Forecast by Market Taxonomy 17.5.3.2.1. By Treatment 17.5.3.2.2. By Route of Administration 17.5.3.2.3. By Distribution Channel 17.5.4. South Africa Market Analysis 17.5.4.1. Introduction 17.5.4.2. Market Analysis and Forecast by Market Taxonomy 17.5.4.2.1. By Treatment 17.5.4.2.2. By Route of Administration 17.5.4.2.3. By Distribution Channel 17.6. Market Trends 17.7. Key Market Participants - Intensity Mapping 17.8. Drivers and Restraints - Impact Analysis 18. Market Structure Analysis 18.1. Market Analysis by Tier of Companies 18.2. Market Share Analysis of Top Players 18.3. Market Presence Analysis 19. Competition Analysis 19.1. Competition Dashboard 19.2. Branding and Promotional Strategies, By Key Players 19.3. Key Development Analysis 19.4. Competition Deep Dive 19.4.1. Johnson & Johnson 19.4.1.1. Overview 19.4.1.2. Product Portfolio 19.4.1.3. Key Financials 19.4.1.4. Sales Footprint 19.4.1.5. SWOT Analysis 19.4.1.6. Strategy Overview 19.4.1.6.1. Marketing Strategy 19.4.1.6.2. Product Strategy 19.4.1.6.3. Channel Strategy 19.4.2. Bayer AG 19.4.2.1. Overview 19.4.2.2. Product Portfolio 19.4.2.3. Key Financials 19.4.2.4. Sales Footprint 19.4.2.5. SWOT Analysis 19.4.2.6. Strategy Overview 19.4.2.6.1. Marketing Strategy 19.4.2.6.2. Product Strategy 19.4.2.6.3. Channel Strategy 19.4.3. Galderma 19.4.3.1. Overview 19.4.3.2. Product Portfolio 19.4.3.3. Key Financials 19.4.3.4. Sales Footprint 19.4.3.5. SWOT Analysis 19.4.3.6. Strategy Overview 19.4.3.6.1. Marketing Strategy 19.4.3.6.2. Product Strategy 19.4.3.6.3. Channel Strategy 19.4.4. Allergan 19.4.4.1. Overview 19.4.4.2. Product Portfolio 19.4.4.3. Key Financials 19.4.4.4. Sales Footprint 19.4.4.5. SWOT Analysis 19.4.4.6. Strategy Overview 19.4.4.6.1. Marketing Strategy 19.4.4.6.2. Product Strategy 19.4.4.6.3. Channel Strategy 19.4.5. Roche 19.4.5.1. Overview 19.4.5.2. Product Portfolio 19.4.5.3. Key Financials 19.4.5.4. Sales Footprint 19.4.5.5. SWOT Analysis 19.4.5.6. Strategy Overview 19.4.5.6.1. Marketing Strategy 19.4.5.6.2. Product Strategy 19.4.5.6.3. Channel Strategy 19.4.6. Valeant Pharmaceuticals 19.4.6.1. Overview 19.4.6.2. Product Portfolio 19.4.6.3. Key Financials 19.4.6.4. Sales Footprint 19.4.6.5. SWOT Analysis 19.4.6.6. Strategy Overview 19.4.6.6.1. Marketing Strategy 19.4.6.6.2. Product Strategy 19.4.6.6.3. Channel Strategy 19.4.7. Stiefel Laboratories 19.4.7.1. Overview 19.4.7.2. Product Portfolio 19.4.7.3. Key Financials 19.4.7.4. Sales Footprint 19.4.7.5. SWOT Analysis 19.4.7.6. Strategy Overview 19.4.7.6.1. Marketing Strategy 19.4.7.6.2. Product Strategy 19.4.7.6.3. Channel Strategy 19.4.8. Pfizer 19.4.8.1. Overview 19.4.8.2. Product Portfolio 19.4.8.3. Key Financials 19.4.8.4. Sales Footprint 19.4.8.5. SWOT Analysis 19.4.8.6. Strategy Overview 19.4.8.6.1. Marketing Strategy 19.4.8.6.2. Product Strategy 19.4.8.6.3. Channel Strategy 19.4.9. Foamix Pharmaceuticals 19.4.9.1. Overview 19.4.9.2. Product Portfolio 19.4.9.3. Key Financials 19.4.9.4. Sales Footprint 19.4.9.5. SWOT Analysis 19.4.9.6. Strategy Overview 19.4.9.6.1. Marketing Strategy 19.4.9.6.2. Product Strategy 19.4.9.6.3. Channel Strategy 19.4.10. La Roche-Posay 19.4.10.1. Overview 19.4.10.2. Product Portfolio 19.4.10.3. Key Financials 19.4.10.4. Sales Footprint 19.4.10.5. SWOT Analysis 19.4.10.6. Strategy Overview 19.4.10.6.1. Marketing Strategy 19.4.10.6.2. Product Strategy 19.4.10.6.3. Channel Strategy 19.4.11. Proactiv 19.4.11.1. Overview 19.4.11.2. Product Portfolio 19.4.11.3. Key Financials 19.4.11.4. Sales Footprint 19.4.11.5. SWOT Analysis 19.4.11.6. Strategy Overview 19.4.11.6.1. Marketing Strategy 19.4.11.6.2. Product Strategy 19.4.11.6.3. Channel Strategy 19.4.12. Cipla Limited 19.4.12.1. Overview 19.4.12.2. Product Portfolio 19.4.12.3. Key Financials 19.4.12.4. Sales Footprint 19.4.12.5. SWOT Analysis 19.4.12.6. Strategy Overview 19.4.12.6.1. Marketing Strategy 19.4.12.6.2. Product Strategy 19.4.12.6.3. Channel Strategy 19.4.13. GlaxoSmithKline Inc. 19.4.13.1. Overview 19.4.13.2. Product Portfolio 19.4.13.3. Key Financials 19.4.13.4. Sales Footprint 19.4.13.5. SWOT Analysis 19.4.13.6. Strategy Overview 19.4.13.6.1. Marketing Strategy 19.4.13.6.2. Product Strategy 19.4.13.6.3. Channel Strategy 19.4.14. Janssen Pharmaceuticals Inc. 19.4.14.1. Overview 19.4.14.2. Product Portfolio 19.4.14.3. Key Financials 19.4.14.4. Sales Footprint 19.4.14.5. SWOT Analysis 19.4.14.6. Strategy Overview 19.4.14.6.1. Marketing Strategy 19.4.14.6.2. Product Strategy 19.4.14.6.3. Channel Strategy 19.4.15. Sanofi 19.4.15.1. Overview 19.4.15.2. Product Portfolio 19.4.15.3. Key Financials 19.4.15.4. Sales Footprint 19.4.15.5. SWOT Analysis 19.4.15.6. Strategy Overview 19.4.15.6.1. Marketing Strategy 19.4.15.6.2. Product Strategy 19.4.15.6.3. Channel Strategy 20. Assumptions and Acronyms Used 21. Research Methodology
Explore Healthcare Insights
View Reports
Moderate-to-Severe Acne Treatment Market
